Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22210018 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors
Condition: Tumors
Intervention: Drug: AMG 386
2 Active, not recruiting Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Drug: AMG 386;   Drug: Paclitaxel;   Drug: AMG 386 Placebo

Study has passed its completion date and status has not been verified in more than two years.